Ainvest Option Flow Digest - 2026-03-18: 🐋 $107.4M Whale Wave on FOMC Day — Mega-Cap Exits, $33M Stablecoin Conviction, and a Layered S&P 500 Fortress

📅 March 18, 2026 | 🚨 FOMC DOT PLOT AT 2PM TODAY | ⚡ Triple Witch in 2 Days | 🔥 8 Unusual Trades, $107.4M Total Flow

---

🎯 Today's $107.4M Institutional Wave: Everything Happening at Once

Today is not a normal options flow day. FOMC rate decision and dot plot land at 2:00 PM ET — the first quarterly dot plot of 2026 with $110 Brent crude, 0.7% GDP, and collapsing rate-cut odds setting the table. Triple Witch arrives Friday (the largest March on record per Citadel Securities). And right in the middle of all this, smart money moved $107.4 million across 8 names — selling mega-cap calls (META $21M, MSFT $20M), loading up on the stablecoin king (CRCL $33M), building a layered S&P 500 put fortress (SPY $17.4M), and collecting premium on high-conviction support floors (PFE 41,000 puts sold).

The message is loud: institutions are repositioning before the most catalyst-dense week of Q1 2026.

Total Flow Tracked: $107,400,000 Dominant Theme: Mega-cap risk reduction + macro hedging + stablecoin conviction Binary Event TODAY: FOMC dot plot 2:00 PM ET (hold at 99.1% probability — the dot plot IS the catalyst) Triple Witch: Friday March 20 — largest March expiry on record

---

📊 Complete Flow Summary Table

---

🚀 The Complete Whale Lineup — All 8 Positions

---

1. 🪙 CRCL — The $33M Stablecoin Conviction Bet

DECODE WHY AN INSTITUTION JUST BET $33M THAT CIRCLE IS THE FUTURE OF REGULATED MONEY

• Flow: $33M — two simultaneous fills on CRCL Sep 18 $80 calls ($22M + $11M at the same timestamp). Nearly doubled the entire existing open interest in one transaction.
• Structure: Deep ITM call buy — stock replacement. $80 strike vs $132.40 spot = $52.40 intrinsic value. Controls 548,700 shares for $33M instead of $72.7M in stock. Delta ~0.90+.
• The thesis: USDC just overtook Tether in transaction volume for the first time since 2019 ($2.2 trillion YTD vs $1.3 trillion for USDT). The GENIUS Act gave Circle a regulatory moat Tether literally cannot replicate as a non-US entity. Federal bank charter in progress.
• Why September? The Sep 18 expiry deliberately captures: Q1 2026 earnings (May), the OCC/Fed GENIUS Act technical standards deadline (July 2026), and ongoing federal bank charter progress. Six months of runway for the entire regulatory thesis to play out.
• The Big Question: Can USDC hold its transaction volume lead over Tether AND navigate OCC technical standards favorably — turning Circle into the undisputed federally chartered dollar layer of the internet?
• Key risk: 95.5% of Circle's revenue comes from Treasury yields on USDC reserves. A 100bps Fed rate cut could vaporize ~$750M in annualized revenue. CRCL has also doubled in 30 days — no clean technical support on the way up.
• Catalyst: Q1 earnings May 2026 | OCC/Fed technical standards deadline July 2026 | Sep 18, 2026 expiry

---

2. 🐋 META — The $21M Deep ITM Call Exit

SEE WHY SMART MONEY JUST CASHED OUT $21M OF META STOCK-REPLACEMENT EXPOSURE ON FOMC DAY

• Flow: $21M — 344 contracts of META Dec 18, 2026 $5 calls SOLD at $615.63 each. Midpoint fill = institutional, clean, deliberate.
• Structure: STC (Sell to Close) — exiting a stock-replacement position. The $5 strike with META at $620.45 = $615.45 of pure intrinsic value. Only $0.18 of time value. This is synthetic stock, not speculation.
• What's really happening: An institution that built this position when META was far lower (likely sub-$500) rode it to the $738 January 29 peak and is now cashing out at $620 — a 16.7% drawdown from highs. This is professional risk management into FOMC + Triple Witch uncertainty, not a prediction META goes to zero.
• The math: 344 contracts = 34,400 share equivalent. At $620.45, that's $21.3M in stock exposure unwound through the derivatives wrapper.
• The Big Question: Is this the first of several institutional exits? When one block of deep ITM calls sells at this scale, institutions rarely do it in a single transaction. Watch the tape for follow-on selling.
• Key levels to watch: $615 gamma support (13.5B GEX) → $610 → $600 (the 28.2B GEX fortress floor). Below $600, things get genuinely messy.
• Catalyst: FOMC TODAY | Triple Witch March 20 | Q1 earnings ~April 29

---

3. 💻 MSFT — The $20M Covered Call Premium Machine

UNDERSTAND WHY BIG MONEY IS COLLECTING $20M TO WAIT OUT MICROSOFT'S RECOVERY

• Flow: $20M — 7,000 contracts of MSFT Mar 19, 2027 $460 calls SOLD at $28.51. Volume exceeded the entire existing open interest of 3,800 in one block. This is definitively new, strategic positioning.
• Structure: STO (Sell to Open) covered call. $460 strike is 16.4% OTM from $395.28 spot. 366 days of premium collected. $28.51 × 100 × 7,000 = $19.957M in cash collected on day one.
• The income math: This institution earns 7.2% annualized yield on MSFT while waiting for the fundamentals to reassert. MSFT is down 26% from its $539 ATH. Selling this LEAP call while holding 700,000 shares says: "If MSFT rallies 16.4% to $460 by next March, fine — sell there. In the meantime, $20M now."
• Critical data point: The 1-year implied move upper bound is $476.72. The seller's breakeven is $460 + $28.51 = $488.51. The seller structured ABOVE the 1-year statistical range on the upside — they think recovery is real but measured, not meteoric.
• The Big Question: Does the $400 gamma wall (82.6B GEX — the single largest gamma concentration on MSFT's board) break before Q3 earnings on April 28-29? That's the first technical test of whether the recovery thesis has real legs.
• Key risk: Azure capacity constraints extend through H2 2026 (CEO Nadella's own words). GPUs are sitting in warehouses for lack of power. Until new data centers come online, the revenue rerating catalyst is delayed.
• Catalyst: FOMC TODAY | Q3 FY2026 earnings ~April 28-29 | Azure capacity expansion H2 2026 | Mar 19, 2027 LEAP expiry

---

4. 🛡️ SPY — The $17.4M Multi-Leg Put Fortress

ANALYZE THE 4-LEG INSTITUTIONAL MACRO HEDGE BUILT SPECIFICALLY FOR TODAY'S FOMC + TRIPLE WITCH + MICRON

• Flow: $17.4M across four SPY April 17 put contracts, executed in two waves 75 minutes apart. Net cost after selling the $635P: ~$10.8M.
• Structure: Wave 1 (11:04 AM): Bear put spread — Buy 5,000x $660P ($6.2M) / Sell 5,000x $635P ($3.3M) = $2.9M net debit. Breakeven $654.15. Wave 2 (12:19 PM): Two standalone long puts — Buy 5,635x $650P ($5.4M) + Buy 5,635x $620P ($2.5M).
• The layered protection: Starts earning below $654 ($660/$635 spread), adds below $640 ($650P standalone), adds tail protection below $616 ($620P disaster insurance). Maximum profit below $620 — all four legs in profit simultaneously.
• Why this construction: The $660 long put strike is the #1 gamma support level on SPY's entire board (536.3B GEX). The $650 standalone strike is the #4 gamma support. The institution placed its protection at the exact levels where dealer hedging flows amplify directional moves. This is not random strike selection.
• The macro backdrop: $110 Brent crude. 0.7% GDP. Core PCE 3.10%. February payrolls -92,000 (third negative in five months). June cut odds collapsed from 60% to 18.4%. This is the stagflation setup — the $620 disaster put is pure tail insurance.
• The Big Question: Is today's dot plot signaling zero 2026 cuts? If Powell removes even one projected cut from the median, all four puts move toward profitability in an afternoon.
• FOMC scenarios: 2 cuts (dovish) = all puts lose value fast. 1 cut maintained = base case, modest $660P gain. 0 cuts (hawkish) = $660P and $650P both ITM, strong gain. Hike language = all four positions profitable.
• Catalyst: FOMC dot plot TODAY 2:00 PM ET | Micron earnings TONIGHT | Triple Witch March 20 | April 17 OPEX

---

5. 💊 MDGL — The $7.5M Rezdiffra Breakout Diagonal

SEE WHY AN INSTITUTION IS PAYING $2.3M NET TO OWN MDGL UPSIDE THROUGH DECEMBER 2026

• Flow: $7.5M notional — three trades in four minutes constructing a precise diagonal call spread.
• Structure: BUY 1,477x Dec 18, 2026 $500 calls (ask fills = aggressive, $4.9M combined). SELL 301x Jan 15, 2027 $480 calls (bid fill = deliberate, $2.6M). Net debit: ~$2.3M. Maximum risk is exactly $2.3M — capped by design.
• The thesis: Rezdiffra (resmetirom) — the first and only FDA/EU-approved MASH therapy — generated $958.4M in full-year 2025 revenue in its very first year on market (+211% YoY in Q4). The $500 call target says this institution believes MDGL reaches ~$500 by December 2026, a 13.5% move from the $442 spot. That's a 9-month thesis on blockbuster trajectory.
• Why a diagonal and not outright calls? The Jan 2027 $480C sale harvests higher premium in the later month to finance the Dec $500C position — capital efficiency, not speculation. Max loss is the $2.3M debit. Max risk is structurally defined.
• The GLP-1 wildcard: The SYH2086 oral GLP-1 license from CSPC ($120M upfront + $2B in milestones) means MDGL could announce Phase I initiation in H1 2026 — the "once-a-day MASH pill" combination thesis. That's the re-rating catalyst the Dec $500C is positioned to capture.
• The Big Question: Does Q1 2026 Rezdiffra revenue top $330M and does management raise the 2026 guidance to $1.5B+? If yes, the $450 gamma resistance wall (strongest level on the board) breaks and the diagonal moves sharply into favorable territory.
• Key risk: The $450 resistance is formidable. MDGL failed to reclaim $480 after its February earnings gap-down. The diagonal only wins if the stock moves materially — range-bound consolidation below $500 = net loss of the $2.3M debit.
• Catalyst: Q1 earnings April/May 2026 | SYH2086 GLP-1 Phase I start H1 2026 | EU country launches rolling | Dec 18, 2026 expiry

---

6. 📉 QQQ — The $4.4M 9-Day Bear Put Spread

DECODE THE FOMC-TIMED BEAR PUT SPREAD — WHY SOMEONE NEEDS $32.5M MAX PAYOUT IN EXACTLY 9 DAYS

• Flow: $7.8M gross / $4.4M net — simultaneously buying 13,000 contracts of Mar 27 $590 puts and selling 13,000 contracts of Mar 27 $565 puts, executed at exactly 10:11:17 AM as FOMC markets opened.
• Structure: Bear put spread. Net debit ~$3.65/spread ($5.09 buy − $1.44 sell). Breakeven: $586.35 (QQQ needs to fall ~2.5% from $601.61). Max profit: $25/spread × 13,000 × 100 = $32.5M if QQQ at or below $565 by March 27. Max loss: $4.4M (100% of net debit).
• The precision: Vol/OI = 1.0x on both legs — these strikes had minimal prior open interest. This is a fresh hedge, not a roll. The $590 long put is the second-largest gamma support level on QQQ's entire board (236.8B GEX). The $600 gamma wall above (448.9B GEX) is the single largest ceiling. The institution placed their hedge exactly at the gamma pivot point.
• Why 9 days? Captures FOMC dot plot TODAY (2:00 PM), Micron earnings TONIGHT, and the largest Triple Witch on record FRIDAY — all in one window. The March 27 expiry gives 7 additional days after Friday's chaos for any post-event momentum to materialize.
• The Big Question: If the dot plot removes a projected rate cut today, QQQ could be below $590 before Powell finishes his 2:30 PM press conference. The $565 max profit zone requires a 6.1% decline — severe but not impossible if MU also disappoints tonight.
• Key risk: A dovish surprise (2 cuts projected) could gap QQQ up 3-4% immediately, making both puts worthless by market close today.
• Catalyst: FOMC dot plot TODAY 2:00 PM ET | Micron Q2 earnings TONIGHT | Triple Witch March 20 | March 27 expiry

---

7. 🏠 HD — The $2.9M Deep ITM LEAP Call Exit

UNDERSTAND WHY AN INSTITUTION SOLD 500 HOME DEPOT LEAP CALLS AND COLLECTED $2.9M ON A BROKEN HOUSING GIANT

• Flow: $2.9M — 500 contracts of HD Jan 15, 2027 $300 calls SOLD at $58 each. Volume of 501 vs OI of 159 = 3.1x — this is a fresh opening sell (STO), not a close.
• Structure: Deep ITM LEAP covered call. $300 strike with HD at $336.74 = $36.74 intrinsic, $21.26 time value. The $21.26 in time value is the "true income" — 6.3% in 10 months, annualizing to ~7.6% vs HD's 2.7% dividend yield.
• The effective exit price: $300 strike + $58 premium = $358 effective delivery. If HD is called away at $300 strike in January, the seller gets the stock appreciation to $358 equivalent — about 6.3% above current price.
• What this communicates: An institution holding ~50,000 HD shares (likely bought near $300) is saying: "I expect housing recovery to take more than 10 months. Pay me $2.9M now. I'll revisit in 2027." HD is down 18% from its $418 ATH. The $340 gamma wall ($6.75B GEX) is the biggest resistance level on the board — and it's only 1% overhead.
• The housing freeze: 30-year mortgage rates stuck above 6% = the DIY renovation demand engine stays cold. Lumber tariffs at 45% (Canadian softwood) being absorbed vs. passed through = margin headwind. Comp sales +0.4% in FY2025 is not the recovery story.
• The Big Question: Does the spring selling season (March-June) finally show +1.5%+ comp sales and confirm the housing recovery thesis? If yes, the seller may regret capping upside at $358. If the freeze continues, they collect $2.9M while waiting.
• Catalyst: FOMC TODAY (rate signal for housing) | Spring selling season Mar-Jun | Q1 FY2026 earnings ~May 19 | Jan 15, 2027 expiry

---

8. 💊 PFE — 41,000 Puts Sold: $1.2M Premium Harvest on $24 Support Conviction

SEE WHY ONE ENTITY SOLD 41,000 PFIZER PUTS IN A SINGLE BLOCK — 76X EXISTING OPEN INTEREST

• Flow: $1.2M — 41,063 contracts of PFE May 15, 2026 $24 puts SOLD at $0.30. Vol/OI = 75.7x. This is not unusual activity. This is singular.
• Structure: 41,063 contracts × 100 shares × $0.30 = $1,231,890 collected. Notional stock obligation: 4.1 million shares at $24 = $98.6M. Breakeven: $23.70. MID fill = negotiated print, not urgency.
• The income math: $0.30 on a $24 strike in 58 days = 1.25% of strike, annualizing to 7.9% — superior to PFE's 6.2% dividend yield on the same capital, for an 11% OTM put below the 52-week low of $24.82.
• What the trade says: The $24 put strike sits below the 52-week low. The seller is saying: "Pfizer does not trade below $24 in the next 58 days without an extraordinary event (dividend cut, catastrophic pipeline failure). I will collect $1.2M for taking that 10-12% tail risk."
• Why confidence in $24? The May 15 implied move lower bound is $26.09 — the $24 strike is $2.09 BELOW even the bearish tail scenario. Gamma support doesn't even operate at $24 — there's no market structure forcing a bounce there. This is pure fundamental conviction.
• The Big Question: Does Pfizer's 349-consecutive-quarter dividend hold? Payout ratio is ~126% on earnings basis. A dividend cut is the only catalyst that could realistically send PFE below $24 in 58 days — and management has explicitly reaffirmed it.
• Key risk: Q1 2026 earnings (April 28) fall inside the May 15 put window. A severe miss compresses the stock toward $25-$26, accelerating put delta. Nothing good happens below $26 GEX support.
• Catalyst: Q1 earnings April 28 | ~20 pivotal study starts H1 2026 | May 15 expiry

---

⚠️ URGENT: FOMC Binary Event — Everything Pivots at 2:00 PM ET Today

THIS IS THE MOST IMPORTANT SECTION IN TODAY'S DIGEST. DO NOT SKIP.

The Fed decision is a near-certain hold (99.1% probability). The dot plot median is the actual catalyst. Every single trade above has a FOMC angle:

Do not establish new directional positions before 2:00 PM ET. Let FOMC clear first.

---

⏰ Critical Expiry Countdown

🔴 TODAY (March 18, 2026)

• 2:00 PM ET — FOMC Dot Plot — binary event affecting all 8 positions
• 2:30 PM ET — Powell Press Conference — language on Iran oil + labor market
• After Close — Micron (MU) Q2 FY2026 Earnings — HBM demand health = QQQ/SPY catalyst

🟠 2 DAYS — Triple Witch (March 20, 2026)

• Largest March Triple Witch on record (Citadel Securities)
• S&P 500 quarterly rebalance — forced selling in deletions (Match Group, Molina, Lamb Weston, Paycom)
• SPY 4-leg put fortress SURVIVES Friday — April 17 expiry stays intact
• QQQ $590/$565 spread LIVES through Friday — March 27 expiry

🟡 9 DAYS — QQQ Bear Put Spread Expires (March 27)

• The $4.4M bet on FOMC-driven QQQ selloff reaches maximum value only at $565 or below
• Maximum $32.5M profit potential if thesis plays out

🟢 MONTHLY — Q1 Earnings Season (April-May)

• April 17: SPY 4-leg put fortress + QQQ spread captures Q1 bank earnings kickoff (JPMorgan April 14)
• ~April 28-29: MSFT Q3 FY2026 earnings — Azure reacceleration test for the $20M covered call writer
• ~April 29: META Q1 2026 earnings — first major catalyst after today's $21M exit
• April 28: PFE Q1 2026 earnings — single biggest risk event within the May 15 put window
• ~May 2026: MDGL Q1 2026 earnings — Rezdiffra quarterly print (must show $330M+ trajectory)
• ~May 19: HD Q1 FY2026 earnings — spring comp sales reveal

🚀 LONGER DATED — Thesis Catalysts

• May 2026: CRCL Q1 2026 earnings — first test of USDC volume leadership sustainability
• July 2026: OCC/Fed GENIUS Act technical standards — binary catalyst for CRCL (Sep 18 expiry positioned around this)
• September 18, 2026: CRCL $33M deep ITM call expiry — full stablecoin thesis resolution
• December 18, 2026: MDGL diagonal long call expiry — Rezdiffra + GLP-1 thesis resolution
• January 15, 2027: MDGL short $480 call + HD deep ITM LEAP expiry
• March 19, 2027: MSFT $20M covered call expiry — full 12-month thesis resolution

---

📈 Smart Money Themes: What Institutions Are Really Betting

🏦 Theme 1: Mega-Cap Exit / Profit Reduction ($41M — META + MSFT)

Two of today's biggest trades are exits from mega-cap technology exposure. Both META (-17% from Jan 29 high) and MSFT (-26% from Oct 2025 ATH) have been grinding lower on capex anxiety. Today's sellers aren't predicting disaster — they're reducing risk into the highest-uncertainty macro event of the quarter. The message: when you're sitting on a $21M stock-equivalent META position or a $700,000-share MSFT block, FOMC day is the wrong day to be fully exposed.

🪙 Theme 2: Stablecoin Regulatory Moat ($33M — CRCL)

The single largest bullish conviction trade of the day. USDC overtook Tether in transaction volume for the first time since 2019. The GENIUS Act created a regulatory framework that a Cayman Islands-domiciled Tether fundamentally cannot comply with. An institution just bet $33M that Circle's federal bank charter + USDC's transaction volume dominance = durable competitive moat worth materially more than $132 by September. This is the anti-FOMC trade — stablecoin dominance driven by regulation, not rates.

🛡️ Theme 3: Macro Hedging — Layered Downside Protection ($21.8M — SPY + QQQ)

The most technically precise trades of the day. SPY's 4-leg fortress was placed at gamma pivot levels that amplify dealer flows on any breakdown. QQQ's bear put spread was placed at the exact $590 gamma support level with the $600 gamma wall capping any rally. Combined net cost: ~$15.2M for protection on what could be massive long equity portfolios. These aren't directional bets — they are insurance purchased the morning of a known high-risk event cluster.

💊 Theme 4: Pharma / Biotech Thesis Plays ($8.7M — MDGL + PFE)

Two completely different biotech plays that couldn't be more different in structure. MDGL is a $2.3M net debit 9-month conviction bet on the first-ever FDA-approved MASH therapy reaching blockbuster status and potentially launching a GLP-1 combination. PFE is a $1.2M income harvest on structural support below the 52-week low — 41,000 puts sold by someone who would happily own 4.1 million Pfizer shares at $23.70 and collect 7.1% dividend yield. One is thesis-driven. One is income-driven. Both are high-conviction.

🏘️ Theme 5: Housing / Retail Caution ($2.9M — HD)

Home Depot's $2.9M deep ITM LEAP call sale communicates the most pragmatic view: the housing recovery is more than 10 months away. Mortgage rates above 6%, lumber tariffs at 45%, and flat comp sales don't add up to a stock sprinting through $358. Collect $2.9M now. Revisit the thesis in 2027.

---

🎯 Investor Action Plans

🎰 YOLO Trader (1-2% Portfolio MAX — Understand You May Lose Everything)

Highest risk / highest reward — binary catalyst exposure

1. QQQ Bear Put Spread replica — QQQ March 27 $590P / $565P spread — pure FOMC event play. 9 days. $3.65 net debit. Max payout ~$25/spread if QQQ breaks 6.1%. WAIT until after 2:00 PM ET dot plot before entering. If dot plot is hawkish (0 cuts), this spread has serious momentum. 100% loss if FOMC is dovish.
2. CRCL OTM calls — CRCL Sep 18 $150-$160 calls — lottery ticket on the stablecoin re-rating thesis. Stock must climb 13-21% from already-elevated levels. OCC/Fed July deadline is the binary event. Size 1-2% max. High theta decay.
3. SPY April $660 put (outright) — SPY April 17 $660 put — the highest-delta leg of the institutional fortress. $660 is both the #1 gamma support AND the algorithmic selling trigger. A hawkish dot plot could put this ITM this afternoon. High theta (~$0.40/day). Only enter POST-FOMC if dot plot is hawkish.

Why these work: Binary outcomes anchored to a known catalyst 90 minutes from now. Size is critical. Never more than 2% per position. FOMC day theta is brutal if the market yawns.

---

⚖️ Swing Trader (3-5% Portfolio — 2-8 Week Hold)

Institutional backing + defined catalyst timelines

1. CRCL deep ITM Sep calls — CRCL Sep 18 $80 calls — copy the institutional structure. ~$59-61 per contract (delta ~0.90). Controls 100 shares for 55% less capital. Max loss if CRCL falls to $80 (would require a 40% crash). Target: $150-$155 by summer. Stop: close below $120.
2. MDGL May earnings call — MDGL May 2026 $460 call — near-term Q1 earnings catalyst play on Rezdiffra trajectory. Shorter window than institutional diagonal. $460 is the key gamma resistance to clear. If Q1 revenue tops $330M, this moves hard.
3. META post-FOMC call spread — META Apr 17 $625/$650 call spread — wait for FOMC resolution. If $615 gamma support holds post-FOMC, a bounce toward Q1 earnings April 29 is the thesis. Estimated ~$8-10 net debit, max ~$17-18 at $650. Enter Thursday or Friday only if META holds $615.

Risk management: Stop at 30% of premium paid. Close 50% at 50% gain. FOMC resolution is the entry signal for META — do NOT enter META or MSFT positions before 2:00 PM today.

---

💰 Premium Collector (Income Focus — Sell High IV, Target 5-10% Monthly)

Follow the institutional sellers

1. PFE $25 put — May 2026 — PFE May 15 $25 put — mimic the institutional trade at a better strike. The $24 put is 11% OTM for $0.30. The $25 put is 7.2% OTM for ~$0.40-$0.55 and sits above the gamma support floor. Better premium, still high probability. At $25 effective, dividend yield = 6.7%. Only sell what you can own.
2. MSFT Dec $420 covered calls (for MSFT holders) — MSFT Dec 18 $420 calls — copy the institutional strategy at shorter duration. $420 sits above the $400 gamma wall. Likely fetches $20-25 (5-6% yield). If MSFT recovers to $420 by December, you're called away at a profit AND kept the premium.
3. CRCL covered calls $135-$140 (for CRCL holders) — CRCL Apr $140 calls — collect 3-5% monthly income against existing CRCL shares. $135 is the nearest gamma resistance. Stock doubled in 30 days — some income collection while holding through the thesis is prudent.

Risk management: Close winners at 50-60% of max profit. Never sell naked puts without the capital to own the stock. PFE $25 put = obligation to buy $2,500 of stock per contract at assignment.

---

🛡️ Entry Level Investor (Learning Mode — Build Experience First)

Start with understanding before capital

1. Watch FOMC unfold today (2:00-3:00 PM ET). Before making any trade, observe how SPY and QQQ react to the dot plot. The 4-leg SPY put fortress and QQQ bear put spread are live case studies in how institutions hedge macro events. Track whether SPY breaks below $665 support or bounces through $670 resistance.
2. Study the CRCL $33M trade structure. This is a textbook stock-replacement using deep ITM calls. Compare owning 100 CRCL shares at $132.40 ($13,240) vs. owning 1 CRCL Sep $80 call at ~$60 ($6,000). Same exposure on the upside. Hard $80 floor on the downside. This is the lesson that deep ITM calls teach.
3. Track META and MSFT exits over the next two weeks. These are real-time demonstrations of how covered calls and stock-replacement exits work at institutional scale. When does a sophisticated seller exit? Into FOMC + Triple Witch uncertainty with a 16-26% drawdown from highs. The timing is not coincidental.
4. Paper trade the PFE $24 put concept. Selling 1 put = obligation to buy 100 shares at $24. If PFE stays above $24 through May 15, you keep $30. If assigned, you own 100 PFE at $23.70 effective with 7.1% dividend yield. This is how premium sellers think about "getting paid to buy at your price."

Critical rules: Never risk more than 1% per trade. Do not trade FOMC day until you have 50+ trades of experience. Options can lose 100% of premium in hours on binary event days. Study the Greeks before trading any position described above.

---

🔗 Weekly / Monthly / Quarterly / LEAP Tags

📅 This Week (March 20 — Triple Witch)

• SPY 4-leg put fortress survives Friday, anchored to April 17
• QQQ $590/$565 bear put spread lives through Triple Witch — March 27 expiry

📆 9-Day Event Window (March 27)

• QQQ — $4.4M net bear put spread EXPIRES. FOMC + Micron + Triple Witch must have delivered the move.

📆 Monthly (April 17 OPEX)

• SPY — all four put legs expire. FOMC + CPI + NFP + JPMorgan earnings all captured.

🗓️ Quarterly (May-September Expiries)

• CRCL — Sep 18 quarterly expiry. Q1 earnings + OCC/Fed July deadline + federal bank charter.
• PFE — May 15 monthly OPEX. Q1 earnings April 28 is the key risk event inside this window.
• HD — Q1 earnings ~May 19. Spring selling season the make-or-break.

🚀 LEAPS (December 2026 – March 2027)

• MDGL — Dec 18, 2026 long $500 calls. Jan 15, 2027 short $480 calls. 9-month Rezdiffra + GLP-1 thesis.
• META — Dec 18, 2026 (the exit strike). Q1, Q2 earnings and AI capex narrative play out before this.
• HD — Jan 15, 2027. Housing recovery or continued freeze.
• MSFT — Mar 19, 2027. Full Azure reacceleration thesis window. Q3, Q4 FY2026, FY2027 guidance.

---

🚨 What Could Destroy These Trades

If You Follow the Bulls (CRCL, MDGL)

• CRCL: Fed cuts rates aggressively — every 100bps cut removes ~$750M in annualized Circle revenue (95.5% of revenue is Treasury yield-dependent). Crypto market selloff also drags CRCL regardless of fundamentals. Stock already doubled in 30 days with no clean support built.
• MDGL: Eli Lilly tirzepatide or Novo Nordisk/Akero's efruxifermin receives MASH indication — commoditizing Rezdiffra's first-mover moat. Q1 gross-to-net headwinds management flagged could compress net revenue below $290M and blow up the diagonal's $500 target.

If You Follow the Bears (SPY, QQQ puts)

• SPY / QQQ: Dovish FOMC surprise — 2 cuts projected today. SPY could gap up 3-5%, making all near-the-money puts worthless by close. Iran de-escalation headline (Trump coalition + Strait of Hormuz) could drop Brent $15-20 and trigger a tech rally. Micron beats big with strong HBM commentary.

If You Follow the Income Sellers (MSFT, META, PFE, HD)

• MSFT covered call writer: Azure reacceleration + OpenAI GPT-5 drives MSFT to $490+. Seller gets called away at $460 + $28.51 = $488.51 and misses gains above that level.
• PFE put seller: A dividend cut announcement is the single-day risk that breaches $24 in hours. Payout ratio is 126% on earnings — it's real, management just keeps reaffirming.
• META / HD: Both could rocket to $700 / $400+ if rate environment shifts. The covered call / STC sellers cap their upside at defined levels.

---

🎯 The Bottom Line: $107.4M on FOMC Day Is Not Random

Today's flow tells a coherent story. Sophisticated institutions are doing three things simultaneously:

1. Reducing mega-cap exposure into the binary event. META (-17% from peak) and MSFT (-26% from peak) sellers aren't predicting crashes. They're managing position size into the highest-uncertainty macro event of the quarter with the rational view that recovery is measured, not meteoric.

2. Building layered macro protection. The SPY 4-leg put fortress and QQQ 9-day bear put spread were placed at gamma pivot points with surgical precision — the $660 SPY long put is the #1 gamma support level. The $590 QQQ long put is the #2 gamma support level. These aren't lottery tickets. They are portfolio insurance purchased the morning of a known risk cluster: FOMC + Micron + Triple Witch.

3. Taking conviction positions in secular themes uncorrelated to FOMC. CRCL's $33M bet is the only trade today that doesn't need FOMC to go right — the stablecoin regulatory story is driven by the GENIUS Act and federal bank charter timeline, not dot plot semantics. MDGL's diagonal is a 9-month Rezdiffra + GLP-1 combination thesis. These are the trades with the longest time horizon and the clearest fundamental catalysts.

The FOMC risk is real and it is binary. Do not blindly follow any position above without waiting for the 2:00 PM ET dot plot. A dovish surprise destroys the SPY and QQQ put positions. A hawkish surprise destroys the META and MSFT covered call writers' narrative. Size everything appropriately. The $107.4M you see today is part of much larger portfolios we cannot see — these institutions have offsetting positions we have no visibility into.

---

🔗 Complete Analysis Directory

🪙 Stablecoin / Crypto

• CRCL $33M Deep ITM Call — King of Regulated Stablecoins

🐋 Mega-Cap Exits

• META $21M Deep ITM Call Exit — Smart Money Cashing Out
• MSFT $20M Covered Call — Get Paid $20M to Wait

🛡️ Macro Hedges

• SPY $17.4M 4-Leg Put Fortress — Institutional S&P 500 Hedge
• QQQ $4.4M Bear Put Spread — 9-Day FOMC Hedge

💊 Pharma / Biotech

• MDGL $7.5M Diagonal Spread — Rezdiffra Breakout Thesis
• PFE 41,000 Puts Sold — $24 Support Conviction at 76x OI

🏠 Housing / Retail

• HD $2.9M Deep ITM LEAP Exit — Housing Recovery Delayed

---

📅 Full Catalyst Calendar

---

Total Flow Summary:

• Total Tracked: $107,400,000
• Largest Position: CRCL $33M (31% of total flow) — bullish stablecoin conviction
• Macro Protection: SPY $17.4M + QQQ $4.4M = $21.8M (20% of flow)
• Mega-Cap Exits: META $21M + MSFT $20M = $41M (38% of flow)
• Biotech/Pharma: MDGL $7.5M + PFE $1.2M = $8.7M (8% of flow)
• Housing: HD $2.9M (3% of flow)
• FOMC Day Theme: 6 of 8 trades have direct FOMC sensitivity. 2 (CRCL, MDGL) are thesis-driven and partially independent.

---

⚠️ Options trading involves substantial risk of loss and is not suitable for all investors. This digest is for educational and informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. The unusual options activity described reflects institutional trading decisions that may be part of larger, complex portfolios with offsetting positions not visible to retail traders. FOMC day options trading is particularly risky — implied volatility can collapse immediately after the decision, destroying the value of long options positions regardless of direction. Deep in-the-money options, covered calls, put selling, and multi-leg spreads all carry specific risks that differ materially from simple long call/put positions. Past unusual options activity does not guarantee future performance. Never risk more than you can afford to lose completely. If you do not understand the Greeks, position sizing, or the specific mechanics of each strategy described above, do not trade these positions until you do.

---

About Ainvest Option Flow Digest: Ainvest tracks institutional unusual options activity across US equity markets, surfacing large-block trades that reveal where sophisticated capital is positioning before key catalysts. Every trade in this digest has been verified against the raw tape. All premium figures are derived directly from individual ticker analysis files. This is signal, not noise — but it is your responsibility to size it appropriately.